the future of infection protection

fast-acting universal antivirals for disrupting respiratory infections

we live in an increasingly infectious world.

viral mutation is outpacing innovation.

respiratory infections impact everyone. we are sick of being sick.

the world’s first

fast-acting

universal antiviral

Convenient nasal spray format brings protection within reach

no

needles

prescriptions

metal mouth

rebounds

positive test required

benefits

speed

breadth

accessibility

safety

efficacy

convenience

simplicity

deadly

respiratory infections were the #4 killer globally in 2019 (W.H.O.)

and the #1 killer among children <5 years old.

disruptive

URI’s accounted for 42.8% of all illness from 1990-2019 (The Lancet).

damaging

Economists estimate that COVID-19  cost the United States $16 Trillion (JAMA).

a new approach for infection protection

stop the virus before it has a chance to take hold.

start targeting viral load where it begins:

in the nose

targeting nasal viral load works

reduces your risk of getting sick

reduces severity and time you are sick

reduces the risk of making others sick

Our candidates reduce viral load by >99.999%

Our proprietary technology elegantly replicates the ancient wisdom naturally encoded in your body’s white blood cells with precision dosing, sterility and rapid global scaling.

Our 100% pure, sterile & ultra-low concentration product candidates can safely reduce viral load by 99.999% in <1 minute across 100% of viruses we have tested (9/9).